<DOC>
	<DOC>NCT00403975</DOC>
	<brief_summary>The purpose of this trial is to assess the effectiveness and safety of 2% diquafosol tetrasodium ophthalmic solution versus placebo following 6 weeks of treatment in subjects with mild to moderate dry eye disease.</brief_summary>
	<brief_title>Study of Diquafosol Tetrasodium Ophthalmic Solution in Subjects With Dry Eye Disease</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Eye Diseases</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>best corrected visual acuity in both eyes of at least +0.7 sixmonth documented history of dry eye disease as least mild severity in 1 of the 5 dry eye symptoms corneal fluorescein staining of greater than or equal to 3 and less than or equal to 6 (out of 15) permanent conjunctival goblet cell loss or scarring conditions ongoing contact lens wear current topical ophthalmic medication use</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>